Need professional-grade analysis? Visit stockanalysis.com
$11.81B
25.24
3,604
4.33%
Price Chart
Risk-Adjusted Performance
Medibank Private Ltd (MPL) Price Performance
Medibank Private Ltd (MPL) trades on Australian Securities Exchange in AUD. The company is classified in the Financial Services sector under the Insurance - Specialty industry. The stock currently trades at AUD4.40, up 4.51% from the previous close.
Over the past year, MPL has traded between a low of AUD4.10 and a high of AUD5.15. The stock has gained 1.9% over this period. It is currently 14.6% below its 52-week high.
Medibank Private Ltd has a market capitalization of $11.81B, with a price-to-earnings ratio of 25.24 and a dividend yield of 4.33%.
About Medibank Private Ltd
Medibank Private Limited provides private health insurance in Australia. The company operates in two segments, Health Insurance and Medibank Health. The Health Insurance segment provides private health insurance products, including hospital cover that offers members with health cover for hospital treatments; and ancillary cover, which provides members with health cover for healthcare services comprising dental, optical, and physiotherapy, as well as offers health insurance products to overseas visitors and students. The Medibank Health segment provides health management and in-home care services, as well as a range of telehealth and primary care services to government and corporate customers; and distributes travel, life, and pet insurance products. It underwrites and distributes private health insurance policies under the Medibank and ahm brands for resident and nonresident customers. The company was founded in 1976 and is based in Docklands, Australia.
Company Info
- Sector
- Financial Services
- Industry
- Insurance - Specialty
- Exchange
- Australian Securities Exchange
- Currency
- AUD
- Country
- Australia
Financial Metrics
- Revenue (TTM)
- $8.77B
- EBITDA
- $722.20M
- Profit Margin
- 5.28%
- EPS (TTM)
- 0.17
- Book Value
- 0.85
Technical Indicators
- 52 Week High
- A$5.20
- 52 Week Low
- A$4.06
- 50 Day MA
- A$4.52
- 200 Day MA
- A$4.80
- Beta
- 0.03
Valuation
- Trailing P/E
- 25.24
- Forward P/E
- 16.34
- Price/Sales
- 1.35
- Price/Book
- 5.03
- Enterprise Value
- $11.58B